Abiopharma

AFC Announces Dividend for the Second Quarter 2026

Preclinical Data for OPKO Biologics OPK8801001 in Acromegaly Presented at ENDO 2026

The Shift to Digital Credentials Accelerates: OneSpan Launches Early Access at Identiverse

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.

Rectitude Holdings Ltd Secures Additional AIMS System Orders for Major Infrastructure and Residential Projects Across Singapore

ASML reports transactions under its current share buyback program

Byrna Technologies Realigns Sales and Marketing Function to Strengthen Brand Messaging and Accelerate Retail Expansion; Appoints HLK as Agency of Record

Swarmer and Molfar Partner to Integrate Verified Intelligence Data for Autonomous Systems

Oxford Lane Capital Corp. Provides May 2026 Net Asset Value Update